Upload File

the association of an hpv16 oncogene variant with hla-b7 has implications for vaccine design in...

  • Home
  • Documents
  • The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer
7
© 1995 Nature Publishing Group http://www.nature.com/naturemedicine

Upload: ls

Post on 29-Jul-2016

212 views

Category:

Documents


0 download

Report

TRANSCRIPT

Page 1: The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

© 1995 Nature Publishing Group http://www.nature.com/naturemedicine

Page 2: The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

© 1995 Nature Publishing Group http://www.nature.com/naturemedicine

Page 3: The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

© 1995 Nature Publishing Group http://www.nature.com/naturemedicine

Page 4: The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

© 1995 Nature Publishing Group http://www.nature.com/naturemedicine

Page 5: The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

© 1995 Nature Publishing Group http://www.nature.com/naturemedicine

Page 6: The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

© 1995 Nature Publishing Group http://www.nature.com/naturemedicine

Page 7: The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

© 1995 Nature Publishing Group http://www.nature.com/naturemedicine


Webinar: HLA Next Generation Sequencing (NGS) Program Handouts/HLA NGS Webinar... · Future direction of HLA typing • Current HLA typing methods (SSO, SSP, Sanger) will be replaced

Anticorpos anti-HLA no transplante cardíaco Encontro... · 2020-03-03 · POLIMORFISMO HLA Numbers of HLA Alleles HLA Class I Alleles 12,021 HLA Class II Alleles 4,230 HLA Alleles

Dominant-negative missense p53 gene mutation Upstream tumour suppressor gene mutation (ATM) Oncogene amplification (MDM2) Viral oncogene

LABORATORY SERVICES HLA LABORATORY SERVICES HLA …HLA LABORATORY 45-01 Vernon Boulevard Long Island City, NY 11101 Phone: 718.752.4717 Fax: 718.707.3770 Email: [email protected] contiguous

Supplementary Figure S1 A MFI HC-10 HCA-2 P=0.0003 No treatment Cetuximab No treatment EGF HLA-A HLA-B/C HLA-A HLA-B/C HLA-A HLA-B/C P=0.0063 B P

Tumor Suppressor Gene & Proto-Oncogene

AKT1 loss correlates with episomal HPV16 in vulval ... Loss Correlates with Episomal HPV16 in Vulval Intraepithelial Neoplasia Arucha L. Ekeowa-Anderson1,2., Karin J. Purdie1., Karen

Open access Original research Oncogene-specific

Identification of Novel HPV16 Binding Proteins using DNA Affinity Purification

n1 034.pdf · The patient biodata, including diagnosis and types of blood transfusions, and presense ... Pit Ab Pit Ab HLA Ab I-ILA Ab w HLA Ab negative HLA Ab HLA Ab HLA Ab

The octamer binding sitein the HPV16 regulatory region produces

Cross-talk Signaling between HER3 and HPV16 E6 and E7 ... · Translational Science Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in

YMA Khawhar Hla Bu (Thalai Hla te)

0319 RET Proto-Oncogene Testing - Aetna

IMMUNOGENETIC TESTS. MHC = Major histocompability complex HLA = Human lymphocyte antigen HLA class I: HLA-A, B and C Present on all nucleated cells HLA

FOXO Oncogene Brunet

The Royal Society of Chemistry · 25 amplified using primer pair F (HPV16)/R (HPV16) (Table S10), followed by splitting into nine portions and incubation at 95°C with nine groups

Chapter 20 oncogene, anti-oncogene and growth factor The biochemistry and molecular biology department of CMU

Characterization of Events during the Late Stages of HPV16 ... · VIROLOGY 238, 40–52 (1997) ARTICLE NO. VY978768 Characterization of Events during the Late Stages of HPV16 Infection

INTERACTION STUDIES BETWEEN TRUNCATED HPV16/18 …eprints.usm.my/31580/1/Fatin_Athirah.pdf · INTERACTION STUDIES BETWEEN TRUNCATED HPV16/18 E7 ONCOPROTEIN WITH CTCF/YB-1 TRANSCRIPTION

HIV Protease Inhibitors Block HPV16-Induced Murine ......MOLECULAR CANCER THERAPEUTICS | SMALL MOLECULE THERAPEUTICS HIV Protease Inhibitors Block HPV16-Induced Murine CervicalCarcinomaandPromoteVesselNormalizationin

The KRAS Oncogene

M HLA™ HLA-B 24 96 M - Amazon S3HLA+HLA-B+User... · long-range PCR amplification of HLA genes with sequencing on the Illumina MiSeq platform. More specifically HLA-B is amplified

Oncogene-1998-Di Como-2527-39

Research Paper LncRNA MALAT1 was regulated by HPV16 E7

Oncogene Review

oncogene as a transcription activator

Feasibility of HPV16, HPV18, and p16 Expression as

ORIGINAL ARTICLE Evidence That HLA Class I and II ...tion of HLA-DRB1*03-HLA-DQB1*02 with IA-2A (13–16). Both HLA-DRB1*07-HLA-DQA1*(0201 or 0301) and HLA-DRB1*09-HLA-DQA1*0301 haplotypes

From RSV Oncogene Src to YAP Oncogene of the Hippo Tumor ...€¦ · From RSV Oncogene Src to YAP Oncogene of the Hippo Tumor Suppressor Pathway 4th Singapore Sarcoma Meeting Academia,

2013 Roth and Chen Oncogene Review

TCRGeneTransfer:MAGE-C2/HLA-A2andMAGE-A3/HLA-DP4

Methylation status of the E2 binding sites of HPV16 in ... · Methylation status of the E2 binding sites of HPV16 in cervical lesions determined with the Luminex® xMAP™ system

HLA Ligand Atlas: a benign reference of HLA-presented

Differential Expression of HPV16 L2 Gene in Cervical Cancers